{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T19:54:20Z","timestamp":1782762860813,"version":"3.54.5"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T00:00:00Z","timestamp":1594771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T00:00:00Z","timestamp":1594771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Sepsis has no proven pharmacologic treatment other than appropriate antibiotic agents, fluids, vasopressors as needed, and possibly corticosteroids. It is generally initiated mainly by the simultaneous recognition by various components of the innate immune system of either pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs). In the current study, we employed the murine cecal ligation and puncture (CLP) model for sepsis to evaluate the effect of post-CLP infusion of apoptotic cells (Allocetra-OTS) on a CLP severe sepsis model. Cardiovascular evaluation, acute kidney injury (AKI), acute liver injury (ALI), and hematological and metabolic function were evaluated. Cytokine and chemokine profiles were measured by Multiplex ELISA and mitochondrial function, and glycolysis by Seahorse. The Murine Sepsis Score (MSS) was used for disease severity definition. CLP mice had low blood pressure, poor cardiac output, and lung dysfunction, as well as AKI, ALI, and thrombocytopenia, which correlated with the MSS and corresponded to a cytokine\/chemokine storm. Apoptotic cell administration markedly improved the cytokine and chemokine storm and restored the impaired mitochondrial and glycolytic function in white blood cells leading to increased survival, from 6 to 60% (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001), together with a significant improvement in organ dysfunction. We conclude that the deleterious immune response in CLP-induced sepsis can be successfully modified by apoptotic cell infusion.<\/jats:p>","DOI":"10.1038\/s41419-020-02748-8","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T06:04:02Z","timestamp":1594793042000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Apoptotic cell therapy for cytokine storm associated with acute severe sepsis"],"prefix":"10.1038","volume":"11","author":[{"given":"Netanel","family":"Karbian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avraham","family":"Abutbul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja","family":"el-Amore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Eliaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8014-0702","authenticated-orcid":false,"given":"Ronen","family":"Beeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barak","family":"Reicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dror","family":"Mevorach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,15]]},"reference":[{"key":"2748_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ccc.2017.08.012","volume":"34","author":"J-L Vincent","year":"2018","unstructured":"Vincent, J.-L. & Grimaldi, D. Novel interventions: what\u2019s new and the future. Crit. Care Clin. 34, 161\u2013173 (2018).","journal-title":"Crit. Care Clin."},{"key":"2748_CR2","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.2147\/DDDT.S78757","volume":"9","author":"I Martin-Loeches","year":"2015","unstructured":"Martin-Loeches, I., Levy, M. M. & Artigas, A. Management of severe sepsis: advances, challenges, and current status. Drug Des. Devel. Ther. 9, 2079\u20132088 (2015).","journal-title":"Drug Des. Devel. Ther."},{"key":"2748_CR3","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1007\/s12325-017-0622-8","volume":"34","author":"J Rello","year":"2017","unstructured":"Rello, J., Valenzuela-S\u00e1nchez, F., Ruiz-Rodriguez, M. & Moyano, S. Sepsis: a review of advances in management. Adv. Ther. 34, 2393\u20132411 (2017).","journal-title":"Adv. Ther."},{"key":"2748_CR4","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1705835","volume":"378","author":"B Venkatesh","year":"2018","unstructured":"Venkatesh, B. et al. Adjunctive glucocorticoid therapy in patients with septic shock. N. Engl. J. Med. 378, 797\u2013808 (2018).","journal-title":"N. Engl. J. Med."},{"key":"2748_CR5","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00134-004-2157-0","volume":"30","author":"S Finfer","year":"2004","unstructured":"Finfer, S. et al. Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units. Intensive Care Med. 30, 589\u2013596 (2004).","journal-title":"Intensive Care Med."},{"key":"2748_CR6","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1164\/rccm.201504-0781OC","volume":"193","author":"C Fleischmann","year":"2016","unstructured":"Fleischmann, C. et al. Assessment of global incidence and mortality of hospital-treated sepsis. current estimates and limitations. Am. J. Respir. Crit. Care Med. 193, 259\u2013272 (2016).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2748_CR7","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1001\/jama.2014.5804","volume":"312","author":"V Liu","year":"2014","unstructured":"Liu, V. et al. Hospital deaths in patients with sepsis from 2 independent cohorts. JAMA 312, 90 (2014).","journal-title":"JAMA"},{"key":"2748_CR8","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/S1473-3099(17)30322-5","volume":"17","author":"FR Machado","year":"2017","unstructured":"Machado, F. R. et al. The epidemiology of sepsis in Brazilian intensive care units (the Sepsis PREvalence Assessment Database, SPREAD): an observational study. Lancet Infect. Dis. 17, 1180\u20131189 (2017).","journal-title":"Lancet Infect. Dis."},{"key":"2748_CR9","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1056\/NEJMp1707170","volume":"377","author":"K Reinhart","year":"2017","unstructured":"Reinhart, K. et al. Recognizing sepsis as a global health priority\u2014a WHO resolution. N. Engl. J. Med. 377, 414\u2013417 (2017).","journal-title":"N. Engl. J. Med."},{"key":"2748_CR10","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1001\/jama.2017.13836","volume":"318","author":"C Rhee","year":"2017","unstructured":"Rhee, C. et al. Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009\u20132014. JAMA 318, 1241 (2017).","journal-title":"JAMA"},{"key":"2748_CR11","doi-asserted-by":"publisher","first-page":"16045","DOI":"10.1038\/nrdp.2016.45","volume":"2","author":"RS Hotchkiss","year":"2016","unstructured":"Hotchkiss, R. S. et al. Sepsis and septic shock. Nat. Rev. Dis. Prim. 2, 16045 (2016).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"2748_CR12","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2017.36","volume":"17","author":"T van der Poll","year":"2017","unstructured":"van der Poll, T., van de Veerdonk, F. L., Scicluna, B. P. & Netea, M. G. The immunopathology of sepsis and potential therapeutic targets. Nat. Rev. Immunol. 17, 407\u2013420 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"2748_CR13","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1600-065X.2012.01146.x","volume":"249","author":"D Tang","year":"2012","unstructured":"Tang, D., Kang, R., Coyne, C. B., Zeh, H. J. & Lotze, M. T. PAMPs and DAMPs: signal 0s that spur autophagy and immunity. Immunol. Rev. 249, 158\u2013175 (2012).","journal-title":"Immunol. Rev."},{"key":"2748_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-32275-8","volume":"8","author":"H Matsumoto","year":"2018","unstructured":"Matsumoto, H. et al. The clinical importance of a cytokine network in the acute phase of sepsis. Sci. Rep. 8, 1\u20134 (2018).","journal-title":"Sci. Rep."},{"key":"2748_CR15","first-page":"669","volume":"27","author":"H Chaudhry","year":"2013","unstructured":"Chaudhry, H. et al. Role of cytokines as a double-edged sword in sepsis. Vivo 27, 669\u2013684 (2013).","journal-title":"Vivo"},{"key":"2748_CR16","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1208623","volume":"369","author":"DC Angus","year":"2013","unstructured":"Angus, D. C. & van der Poll, T. Severe sepsis and septic. Shock. N. Engl. J. Med. 369, 840\u2013851 (2013).","journal-title":"Shock. N. Engl. J. Med."},{"key":"2748_CR17","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1097\/00003246-199510000-00007","volume":"23","author":"JC Marshall","year":"1995","unstructured":"Marshall, J. C. et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit. Care Med. 23, 1638\u20131652 (1995).","journal-title":"Crit. Care Med."},{"key":"2748_CR18","doi-asserted-by":"publisher","first-page":"s-69","DOI":"10.1089\/sur.2006.7.s2-69","volume":"7","author":"J-L Vincent","year":"2006","unstructured":"Vincent, J.-L. Organ dysfunction in patients with severe sepsis. Surg. Infect. (Larchmt.) 7, s-69\u2013s-72 (2006).","journal-title":"Surg. Infect. (Larchmt.)"},{"key":"2748_CR19","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/imr.12376","volume":"269","author":"KK Penberthy","year":"2016","unstructured":"Penberthy, K. K. & Ravichandran, K. S. Apoptotic cell recognition receptors and scavenger receptors. Immunol. Rev. 269, 44\u201359 (2016).","journal-title":"Immunol. Rev."},{"key":"2748_CR20","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.3389\/fimmu.2017.01356","volume":"8","author":"U Trahtemberg","year":"2017","unstructured":"Trahtemberg, U. & Mevorach, D. Apoptotic cells induced signaling for immune homeostasis in macrophages and dendritic cells. Front. Immunol. 8, 1356 (2017).","journal-title":"Front. Immunol."},{"key":"2748_CR21","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1083\/jcb.201004096","volume":"189","author":"MR Elliott","year":"2010","unstructured":"Elliott, M. R. & Ravichandran, K. S. Clearance of apoptotic cells: implications in health and disease. J. Cell Biol. 189, 1059\u20131070 (2010).","journal-title":"J. Cell Biol."},{"key":"2748_CR22","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1089\/sur.2016.021","volume":"17","author":"AJ Lewis","year":"2016","unstructured":"Lewis, A. J., Seymour, C. W. & Rosengart, M. R. Current murine models of sepsis. Surg. Infect. (Larchmt.). 17, 385\u2013393 (2016).","journal-title":"Surg. Infect. (Larchmt.)."},{"key":"2748_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/ilar\/ilx007","volume":"58","author":"JA Stortz","year":"2017","unstructured":"Stortz, J. A. et al. Murine models of sepsis and trauma: Can We bridge the gap? ILAR J. 58, 90\u2013105 (2017).","journal-title":"ILAR J."},{"key":"2748_CR24","first-page":"19.13","volume":"Chapter 19","author":"AG Cuenca","year":"2010","unstructured":"Cuenca, A. G., Delano, M. J., Kelly-Scumpia, K. M., Moldawer, L. L. & Efron, P. A. Cecal ligation and puncture. Curr. Protoc. Immunol. Chapter 19, 19.13 (2010).","journal-title":"Curr. Protoc. Immunol."},{"key":"2748_CR25","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.bbmt.2013.10.010","volume":"20","author":"D Mevorach","year":"2014","unstructured":"Mevorach, D. et al. Single infusion of donor mononuclear early apoptotic cells as prophylaxis for graft-versus-host disease in myeloablative HLA-matched allogeneic bone marrow transplantation: a phase I\/IIa clinical trial. Biol. Blood Marrow Transplant. 20, 58\u201365 (2014).","journal-title":"Biol. Blood Marrow Transplant."},{"key":"2748_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-014-0511-3","volume":"18","author":"C Coletta","year":"2014","unstructured":"Coletta, C. et al. Endothelial dysfunction is a potential contributor to multiple organ failure and mortality in aged mice subjected to septic shock: preclinical studies in a murine model of cecal ligation and puncture. Crit. Care 18, 511 (2014).","journal-title":"Crit. Care"},{"key":"2748_CR27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12929-017-0370-8","volume":"24","author":"S Seemann","year":"2017","unstructured":"Seemann, S., Zohles, F. & Lupp, A. Comprehensive comparison of three different animal models for systemic inflammation. J. Biomed. Sci. 24, 60 (2017).","journal-title":"J. Biomed. Sci."},{"key":"2748_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s40635-016-0096-z","volume":"4","author":"S Ruiz","year":"2016","unstructured":"Ruiz, S. et al. Sepsis modeling in mice: ligation length is a major severity factor in cecal ligation and puncture. Intensive Care Med. Exp. 4, 22 (2016).","journal-title":"Intensive Care Med. Exp."},{"key":"2748_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s40635-015-0048-z","volume":"3","author":"S Drechsler","year":"2015","unstructured":"Drechsler, S. et al. Why do they die? Comparison of selected aspects of organ injury and dysfunction in mice surviving and dying in acute abdominal sepsis. Intensive care Med. Exp. 3, 48 (2015).","journal-title":"Intensive care Med. Exp."},{"key":"2748_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-7-233","volume":"7","author":"B Shrum","year":"2014","unstructured":"Shrum, B. et al. A robust scoring system to evaluate sepsis severity in an animal model. BMC Res. Notes 7, 233 (2014).","journal-title":"BMC Res. Notes"},{"key":"2748_CR31","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/ki.2008.346","volume":"74","author":"K Doi","year":"2008","unstructured":"Doi, K. et al. Pre-existing renal disease promotes sepsis-induced acute kidney injury and worsens outcome. Kidney Int. 74, 1017\u20131025 (2008).","journal-title":"Kidney Int."},{"key":"2748_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/SHK.0000000000000073","volume":"41","author":"FL Craciun","year":"2014","unstructured":"Craciun, F. L. et al. Early murine polymicrobial sepsis predominantly causes renal injury. Shock 41, 97\u2013103 (2014).","journal-title":"Shock"},{"key":"2748_CR33","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1177\/0300060518764717","volume":"46","author":"J-L Li","year":"2018","unstructured":"Li, J.-L. et al. Assessment of clinical sepsis-associated biomarkers in a septic mouse model. J. Int. Med. Res. 46, 2410\u20132422 (2018).","journal-title":"J. Int. Med. Res."},{"key":"2748_CR34","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1681\/ASN.2010040430","volume":"22","author":"DL Rosin","year":"2011","unstructured":"Rosin, D. L. & Okusa, M. D. Dangers within: DAMP responses to damage and cell death in kidney disease. J. Am. Soc. Nephrol. 22, 416\u2013425 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"2748_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/ki.2011.120","volume":"80","author":"A Havasi","year":"2011","unstructured":"Havasi, A. & Borkan, S. C. Apoptosis and acute kidney injury. Kidney Int. 80, 29\u201340 (2011).","journal-title":"Kidney Int."},{"key":"2748_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/cc12540","volume":"17","author":"GP Otto","year":"2013","unstructured":"Otto, G. P., Busch, M., Sossdorf, M. & Claus, R. A. Impact of sepsis-associated cytokine storm on plasma NGAL during acute kidney injury in a model of polymicrobial sepsis. Crit. Care 17, 419 (2013).","journal-title":"Crit. Care"},{"key":"2748_CR37","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3109\/08830185.2014.889129","volume":"33","author":"J Yan","year":"2014","unstructured":"Yan, J., Li, S. & Li, S. The role of the liver in sepsis. Int. Rev. Immunol. 33, 498\u2013510 (2014).","journal-title":"Int. Rev. Immunol."},{"key":"2748_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/cc11381","volume":"16","author":"N Nesseler","year":"2012","unstructured":"Nesseler, N. et al. Clinical review: the liver in sepsis. Crit. Care 16, 1\u20138 (2012).","journal-title":"Crit. Care"},{"key":"2748_CR39","doi-asserted-by":"publisher","first-page":"547","DOI":"10.17219\/acem\/68363","volume":"27","author":"E Wo\u017anica","year":"2018","unstructured":"Wo\u017anica, E., Inglot, M., Wo\u017anica, R. & \u0141ysenko, L. Liver dysfunction in sepsis. Adv. Clin. Exp. Med. 27, 547\u2013552 (2018).","journal-title":"Adv. Clin. Exp. Med."},{"key":"2748_CR40","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4103\/2321-3868.132689","volume":"2","author":"Y Yao","year":"2014","unstructured":"Yao, Y., Wang, D. & Yin, Y. Advances in sepsis-associated liver dysfunction. Burn. Trauma 2, 97 (2014).","journal-title":"Burn. Trauma"},{"key":"2748_CR41","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1182\/blood-2015-11-680744","volume":"127","author":"TAM Claushuis","year":"2016","unstructured":"Claushuis, T. A. M. et al. Thrombocytopenia is associated with a dysregulated host response in critically ill sepsis patients. Blood 127, 3062\u20133072 (2016).","journal-title":"Blood"},{"key":"2748_CR42","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1177\/1751143718765407","volume":"19","author":"R Davies","year":"2018","unstructured":"Davies, R., O\u2019Dea, K. & Gordon, A. Immune therapy in sepsis: Are we ready to try again? J. Intensive Care Soc. 19, 326\u2013344 (2018).","journal-title":"J. Intensive Care Soc."},{"key":"2748_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-017-0337-7","volume":"7","author":"A Dewitte","year":"2017","unstructured":"Dewitte, A. et al. Blood platelets and sepsis pathophysiology: a new therapeutic prospect in critical ill patients? Ann. Intensive Care 7, 115 (2017).","journal-title":"Ann. Intensive Care"},{"key":"2748_CR44","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/cyto.b.21270","volume":"90","author":"G Monneret","year":"2016","unstructured":"Monneret, G. & Venet, F. Sepsis-induced immune alterations monitoring by flow cytometry as a promising tool for individualized therapy. Cytom. Part B - Clin. Cytom. 90, 376\u2013386 (2016).","journal-title":"Cytom. Part B - Clin. Cytom."},{"key":"2748_CR45","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s00277-014-2086-0","volume":"93","author":"O Penack","year":"2014","unstructured":"Penack, O. et al. Management of sepsis in neutropenic patients: 2014 Updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO). Ann. Hematol. 93, 1083\u20131095 (2014).","journal-title":"Ann. Hematol."},{"key":"2748_CR46","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1159\/000362554","volume":"6","author":"JJ Grailer","year":"2014","unstructured":"Grailer, J. J., Kalbitz, M., Zetoune, F. S. & Ward, P. A. Persistent neutrophil dysfunction and suppression of acute lung injury in mice following cecal ligation and puncture sepsis. J. Innate Immun. 6, 695\u2013705 (2014).","journal-title":"J. Innate Immun."},{"key":"2748_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-9255-10-7","volume":"10","author":"J Song","year":"2013","unstructured":"Song, J. et al. Novel biomarkers for early prediction of sepsis-induced disseminated intravascular coagulation in a mouse cecal ligation and puncture model. J. Inflamm. 10, 1\u201310 (2013).","journal-title":"J. Inflamm."},{"key":"2748_CR48","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201708712","volume":"10","author":"L Van Wyngene","year":"2018","unstructured":"Van Wyngene, L., Vandewalle, J. & Libert, C. Reprogramming of basic metabolic pathways in microbial sepsis: therapeutic targets at last? EMBO Mol. Med. 10, e8712 (2018).","journal-title":"EMBO Mol. Med."},{"key":"2748_CR49","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1161\/CIRCRESAHA.117.311327","volume":"121","author":"M DeBerge","year":"2017","unstructured":"DeBerge, M. et al. MerTK cleavage on resident cardiac macrophages compromises repair after myocardial ischemia reperfusion injury. Circ. Res. 121, 930\u2013940 (2017).","journal-title":"Circ. Res."},{"key":"2748_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10626-x","volume":"10","author":"JJ Mart\u00ednez-Garc\u00eda","year":"2019","unstructured":"Mart\u00ednez-Garc\u00eda, J. J. et al. P2X7 receptor induces mitochondrial failure in monocytes and compromises NLRP3 inflammasome activation during sepsis. Nat. Commun. 10, 2711 (2019).","journal-title":"Nat. Commun."},{"key":"2748_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/cc12543","volume":"17","author":"F Beloncle","year":"2013","unstructured":"Beloncle, F., Lerolle, N., Radermacher, P. & Asfar, P. Target blood pressure in sepsis: between a rock and a hard place. Crit. Care 17, 126 (2013).","journal-title":"Crit. Care"},{"key":"2748_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/2052-0492-2-2","volume":"2","author":"Y Koh","year":"2014","unstructured":"Koh, Y. Update in acute respiratory distress syndrome. J. Intensive Care 2, 2 (2014).","journal-title":"J. Intensive Care"},{"key":"2748_CR53","doi-asserted-by":"publisher","first-page":"R74","DOI":"10.1186\/cc3025","volume":"9","author":"GS Martin","year":"2005","unstructured":"Martin, G. S., Eaton, S., Mealer, M. & Moss, M. Extravascular lung water in patients with severe sepsis: a prospective cohort study. Crit. Care 9, R74\u2013R82 (2005).","journal-title":"Crit. Care"},{"key":"2748_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0079037","volume":"8","author":"R Bhargava","year":"2013","unstructured":"Bhargava, R. et al. Acute lung injury and acute kidney injury are established by four hours in experimental sepsis and are improved with pre, but not post, sepsis administration of TNF-\u03b1 antibodies. PLoS ONE 8, 1\u201311 (2013).","journal-title":"PLoS ONE"},{"key":"2748_CR55","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1096\/fj.201700140R","volume":"31","author":"F Fattahi","year":"2017","unstructured":"Fattahi, F. et al. Complement-induced activation of MAPKs and Akt during sepsis: role in cardiac dysfunction. FASEB J. 31, 4129\u20134139 (2017).","journal-title":"FASEB J."},{"key":"2748_CR56","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer, M. et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315, 801\u2013810 (2016).","journal-title":"JAMA"},{"key":"2748_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/cc5783","volume":"11","author":"FA Bozza","year":"2007","unstructured":"Bozza, F. A. et al. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit. Care 11, R49 (2007).","journal-title":"Crit. Care"},{"key":"2748_CR58","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cytogfr.2014.06.008","volume":"25","author":"S Cheng","year":"2014","unstructured":"Cheng, S., Joosten, L. A. B. & Netea, M. G. The interplay between central metabolism and innate immune responses. Cytokine Growth Factor Rev. 25, 707\u2013713 (2014).","journal-title":"Cytokine Growth Factor Rev."},{"key":"2748_CR59","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/ni.3398","volume":"17","author":"S-C Cheng","year":"2016","unstructured":"Cheng, S.-C. et al. Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis. Nat. Immunol. 17, 406\u2013413 (2016).","journal-title":"Nat. Immunol."},{"key":"2748_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.05.031","volume":"169","author":"S Weis","year":"2017","unstructured":"Weis, S. et al. Metabolic adaptation establishes disease tolerance to sepsis. Cell 169, e14 (2017).","journal-title":"Cell"},{"key":"2748_CR61","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/s41586-018-0735-5","volume":"563","author":"S Morioka","year":"2018","unstructured":"Morioka, S. et al. Efferocytosis induces a novel SLC program to promote glucose uptake and lactate release. Nature 563, 714\u2013718 (2018).","journal-title":"Nature"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-02748-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-02748-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-02748-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T09:09:53Z","timestamp":1760087393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-02748-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,15]]},"references-count":61,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7]]}},"alternative-id":["2748"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-02748-8","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,15]]},"assertion":[{"value":"5 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest. B. Reicher is an employee of Enlivex Therapeutics Ltd.; D. Mevorach is a consultant and CMO of Enlivex Therapeutics Ltd.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"535"}}